These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26029218)

  • 1. Development of cross-protective influenza a vaccines based on cellular responses.
    Soema PC; van Riet E; Kersten G; Amorij JP
    Front Immunol; 2015; 6():237. PubMed ID: 26029218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
    Altenburg AF; Rimmelzwaan GF; de Vries RD
    Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice.
    Di Mario G; Garulli B; Sciaraffia E; Facchini M; Donatelli I; Castrucci MR
    Virol J; 2016 Mar; 13():56. PubMed ID: 27036323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines.
    Sridhar S
    Front Immunol; 2016; 7():195. PubMed ID: 27242800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.
    Rosendahl Huber SK; Camps MG; Jacobi RH; Mouthaan J; van Dijken H; van Beek J; Ossendorp F; de Jonge J
    PLoS One; 2015; 10(6):e0127969. PubMed ID: 26046664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populations.
    Liu J; Wu B; Zhang S; Tan S; Sun Y; Chen Z; Qin Y; Sun M; Shi G; Wu Y; Sun M; Liu N; Ning K; Ma Y; Gao B; Yan J; Zhu F; Wang H; Gao GF
    Eur J Immunol; 2013 Aug; 43(8):2055-69. PubMed ID: 23681926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
    Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial Protection against Porcine Influenza A Virus by a Hemagglutinin-Expressing Virus Replicon Particle Vaccine in the Absence of Neutralizing Antibodies.
    Ricklin ME; Vielle NJ; Python S; Brechbühl D; Zumkehr B; Posthaus H; Zimmer G; Summerfield A
    Front Immunol; 2016; 7():253. PubMed ID: 27446083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin.
    Staneková Z; Adkins I; Kosová M; Janulíková J; Sebo P; Varečková E
    Antiviral Res; 2013 Jan; 97(1):24-35. PubMed ID: 23036818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza.
    Baranowska M; Hauge AG; Hoornaert C; Bogen B; Grødeland G
    Vaccine; 2015 Dec; 33(49):6988-96. PubMed ID: 26387432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress on adenovirus-vectored universal influenza vaccines.
    Xiang K; Ying G; Yan Z; Shanshan Y; Lei Z; Hongjun L; Maosheng S
    Hum Vaccin Immunother; 2015; 11(5):1209-22. PubMed ID: 25876176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza Disease.
    Lambert L; Kinnear E; McDonald JU; Grodeland G; Bogen B; Stubsrud E; Lindeberg MM; Fredriksen AB; Tregoning JS
    Front Immunol; 2016; 7():321. PubMed ID: 27602032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
    Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
    Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccine.
    Ju Y; Fan H; Liu J; Hu J; Li X; Li C; Chen L; Gao Q; Gao GF; Meng S
    Vaccine; 2014 May; 32(23):2703-11. PubMed ID: 24699472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines.
    Mullin J; Ahmed MS; Sharma R; Upile N; Beer H; Achar P; Puksuriwong S; Ferrara F; Temperton N; McNamara P; Lambe T; Gilbert SC; Zhang Q
    Vaccine; 2016 Mar; 34(14):1688-95. PubMed ID: 26902548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge.
    Kheiri MT; Jamali A; Shenagari M; Hashemi H; Sabahi F; Atyabi F; Saghiri R
    Antiviral Res; 2012 Sep; 95(3):229-36. PubMed ID: 22809863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against H5N1 by multiple immunizations with seasonal influenza vaccine in mice is correlated with H5 cross-reactive antibodies.
    Roos A; Roozendaal R; Theeuwsen J; Riahi S; Vaneman J; Tolboom J; Dekking L; Koudstaal W; Goudsmit J; Radošević K
    Vaccine; 2015 Mar; 33(14):1739-47. PubMed ID: 25659276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B.
    Gong X; Yin H; Shi Y; He X; Yu Y; Guan S; Kuai Z; Haji NM; Haji NM; Kong W; Shan Y
    Emerg Microbes Infect; 2016 May; 5(5):e51. PubMed ID: 27222326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.